Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 19Recruiting 10Active not recruiting 5Unknown 2Enrolling by invitation 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2CNS 1

Conditions

Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Leukemia, Lymphocytic, Chronic, B-Cell 6Neoplasms 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 4Multiple Myeloma 4Recurrence 3Pain 3Lymphoma, B-Cell 3Hematologic Neoplasms 3Anxiety Disorders 3Prostatic Neoplasms 2Lymphoproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lung Neoplasms 2Leukemia, B-Cell 2Leukemia 2Irritable Bowel Syndrome 2Hypertension 2Hodgkin Disease 2Depression 2Dementia 2Cognitive Dysfunction 2Atrial Fibrillation 2Asthma 2

Interventions

7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Cognitive Dysfunction × Lymphoid × Clear all
NCT06723015 2025-11-18

Tau PET Outcomes With Anti-amyloid Immunotherapies

Mayo Clinic

Phase 2 Enrolling by invitation
135 enrolled
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT06245031 2024-05-07

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Cognito Therapeutics, Inc.

Phase NA Enrolling by invitation
402 enrolled
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡